BIOMAT Database Logo BIOMAT Database Logo

Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. 1994

T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065.

L-692,585 is a 2-hydroxypropyl derivative of L-692,429, both novel non-peptidyl growth hormone (GH) secretagogues. The effects of single and repeated intravenous administration of L-692,585 on serum or plasma GH and other hormones in beagles were evaluated. In a balanced 8-dog dose-ranging study, compared to the saline control with a mean (+/- S.E.M.) after-dose serum GH peak of 6.1 +/- 1.3 ng/ml, L-692,585 significantly increased (P < 0.05) peak GH concentrations 4.3-fold (32.5 +/- 7.0 ng/ml) at a dose of 0.005 mg/kg, 7-fold (49.4 +/- 10.6 ng/ml) at a dose of 0.02 mg/kg, and 21-fold (134.3 +/- 29.0 ng/ml) at a dose of 0.10 mg/kg. Total GH release, expressed as area under the curve, showed a similar dose-dependent increase. Peak GH levels were recorded at 5 or 15 min after dosing with the levels returning to near baseline by 90 min. Serum cortisol levels were increased above saline control levels in a dose-dependent manner; however, the increases were modest compared to the GH increases. Based on peak responses and total GH release, L-692,585 was 10- to 20-fold and 2- to 2.5-fold more potent than L-692,429 and the growth hormone releasing peptide, GHRP-6, respectively. When L-692,585 was administered once daily for 14 consecutive days at 0, 0.01 or 0.10 mg/kg to each of 6 dogs, peak plasma GH levels and total GH release on days 1, 8 and 15 significantly increased in a dose-dependent manner, and no desensitization was evident.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
A novel non-peptidyl growth hormone secretagogue.
January 1993, Hormone research,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Intracerebroventricular and intravenous administration of growth hormone secretagogue L-692,585, somatostatin, neuropeptide Y and galanin in pig: dose-dependent effects on growth hormone secretion.
May 2010, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Effect of repeated L-histidine administration on plasma prolactin and growth hormone levels in rats.
April 2002, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations.
January 1991, Psychoneuroendocrinology,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
[Responses of plasma cortisol, human growth hormone and insulin following intravenous administration of (gly-l)-ACTH(1-18)-octadecapeptide amide (50022-S)].
March 1971, Saishin igaku. Modern medicine,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Mechanism of action of the growth hormone secretagogue, L-692,585, on isolated porcine somatotropes.
December 2002, The Journal of endocrinology,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
May 1993, Physiology & behavior,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
[Plasma levels of growth hormone, insulin and glucose, during sequential intravenous administration of L-arginine and insulin].
January 1972, Archivos de investigacion medica,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Effects of thyroidectomy and thyroxine on plasma growth hormone and insulin levels in rats.
January 1977, Hormone research,
T Jacks, and G Hickey, and F Judith, and J Taylor, and H Chen, and D Krupa, and W Feeney, and W Schoen, and D Ok, and M Fisher
Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs.
December 2001, Endocrine,
Copied contents to your clipboard!